Pinchot Scott N, Al-Wagih Hatem, Schaefer Sarah, Sippel Rebecca, Chen Herbert
Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, WI 53792, USA.
Arch Surg. 2009 Jul;144(7):649-55. doi: 10.1001/archsurg.2009.116.
All thyroid nodules 4 cm or larger should be surgically removed regardless of fine-needle aspiration biopsy (FNAB) results because of an unacceptably high rate of false-negative preoperative biopsy results in these large nodules.
Retrospective cohort study.
Single-institution, tertiary academic referral center.
A retrospective analysis was performed on all patients who underwent surgery for a thyroid nodule 4 cm or larger from May 1, 1994, through January 31, 2007.
Preoperative FNAB results were correlated with final surgical pathologic results. The FNAB results were reported as nondiagnostic, benign, inconclusive (follicular neoplasm), or malignant, whereas the final surgical pathologic data were reported as benign or malignant.
Of 155 patients who underwent a thyroidectomy for a nodule 4 cm or larger, 21 patients (13.5%) had a clinically significant thyroid carcinoma within the nodule on final pathologic analysis. Preoperative cytologic testing of the mass was performed on 97 patients, and the results read as benign for 52, inconclusive for 23, nondiagnostic for 11, and malignant for 11. In lesions 4 cm or larger, 26 of 52 FNAB results reported as benign (50.0%) turned out to be either neoplastic (22) or malignant (4) on final pathologic analysis. Among patients with nondiagnostic FNAB results, the risk of malignant neoplasms was 27.3%.
In patients with thyroid nodules 4 cm or larger, the FNAB results are highly inaccurate, misclassifying half of all patients with reportedly benign lesions. Furthermore, those patients with a nondiagnostic FNAB result display a high risk of differentiated thyroid carcinoma. Therefore, we recommend that diagnostic lobectomy be strongly considered in patients with thyroid nodules 4 cm or larger regardless of FNAB cytologic test results.
所有直径4厘米及以上的甲状腺结节均应进行手术切除,无论细针穿刺活检(FNAB)结果如何,因为这些大结节术前活检结果的假阴性率高得令人无法接受。
回顾性队列研究。
单一机构的三级学术转诊中心。
对1994年5月1日至2007年1月31日期间因直径4厘米及以上甲状腺结节接受手术的所有患者进行回顾性分析。
术前FNAB结果与最终手术病理结果相关。FNAB结果报告为无法诊断、良性、不确定(滤泡性肿瘤)或恶性,而最终手术病理数据报告为良性或恶性。
在155例因直径4厘米及以上结节接受甲状腺切除术的患者中,21例(13.5%)在最终病理分析中结节内存在具有临床意义的甲状腺癌。对97例患者进行了肿块的术前细胞学检查,结果为良性52例,不确定23例,无法诊断11例,恶性11例。在直径4厘米及以上的病变中,最终病理分析显示,52例FNAB结果报告为良性的病变中有26例(50.0%)为肿瘤性(22例)或恶性(4例)。在FNAB结果无法诊断的患者中,恶性肿瘤的风险为27.3%。
对于直径4厘米及以上的甲状腺结节患者,FNAB结果极不准确,将所有报告为良性病变的患者中的一半误诊。此外,FNAB结果无法诊断的患者显示出分化型甲状腺癌的高风险。因此,我们建议,无论FNAB细胞学检查结果如何,对于直径4厘米及以上的甲状腺结节患者,应强烈考虑进行诊断性叶切除术。